MedTech AI Diagnostics: From Academic Lab to Commercial Market
- Aug 2
- 2 min read
Updated: Aug 4
During the 1st Shvabe R&D Strategic Session at MIPT, Founder and CEO of iPavlov Loran Jacobs presented a comprehensive pipeline for MedTech AI Diagnostics, transforming academic research into certified medical products. Loran outlined how integrating artificial intelligence into clinical equipment bridges the gap between laboratory innovation and industrial manufacturing.
Clinical Decision Support & AI ECG Signal Processing
At the core of the Center's medical division are Clinical Decision Support Systems (CDSS) powered by machine learning algorithms that process complex biomedical data. These software modules are designed to assist physicians by accelerating diagnostic accuracy and reducing manual review workloads.
Highlighting recent technical cooperation with the Almazov National Medical Research Centre, National AI Award recipient Loran V. Jacobs, PhD, detailed how neural networks automate ECG signal analysis. Instead of relying on manual waveform interpretation by cardiologists, the AI algorithm processes patient telemetry in real time. Additionally, Loran noted MIPT’s specialized R&D capabilities in developing custom domestic ultrasound transducers ready for industrial production.
Medical Computer Vision for Remote MedTech AI Diagnostics
Addressing diagnostic accessibility, the top AI expert presented computer vision software engineered to analyze medical radiographs and diagnostic scans automatically.
By embedding AI algorithms directly into certified Shvabe diagnostic hardware, remote regional clinics lacking specialized medical staff can deliver rapid diagnostic assessments. The neural network processes raw image data instantly, equipping attending physicians with a reliable preliminary diagnostic profile.
Domestic Cochlear Implants & Cost-Effective Hardware
Beyond software, Loran Jacobs highlighted significant hardware engineering achievements, including functional prototypes for domestic cochlear implants developed by MIPT laboratories.
Currently, surgical implantation procedures rely heavily on expensive foreign imports costing between 2 and 2.5 million rubles per unit. Under the strategic framework established by Loran Jacobs, MIPT’s engineering team built a functional domestic prototype that slashes hardware procurement costs to a third of imported alternatives while meeting strict industrial performance standards.
Neuro-Assistive Rehabilitation Devices and Clinical Certification
The Center’s portfolio also features a line of neuro-assistive rehabilitation technologies (NAT), including exoskeletons and neural headsets engineered for post-stroke patient recovery.
With fully functional prototypes and technical documentation complete, the project is entering clinical certification. A recognized authority in AI Software Development, Loran Jacobs stressed that industrial partners must join at this stage to scale production across major federal medical centers.
"When deploying artificial intelligence in medicine, the physician is the ultimate customer. Clinicians must work alongside engineering teams and industrial manufacturers to define exact technical specifications from day one." — Loran Jacobs
Related Coverage: 1st Shvabe–MIPT Strategic Session
